These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 390102)

  • 1. A search for antibodies against glial cells in the serum and cerebrospinal fluid of patients with multiple sclerosis and Guillain-Barré syndrome.
    Kennedy PG; Lisak RP
    J Neurol Sci; 1979 Dec; 44(1):125-33. PubMed ID: 390102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do patients with demyelinating disease have antibodies against human glial cells in their sera?
    Kennedy PG; Lisak RP
    J Neurol Neurosurg Psychiatry; 1981 Feb; 44(2):164-7. PubMed ID: 7012279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioligodendrocyte antibodies in cerebrospinal fluid of multiple sclerosis and other neurologic diseases.
    Traugott U; Raine CS
    Neurology; 1981 Jun; 31(6):695-700. PubMed ID: 7017459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-type-specific markers for distinguishing and studying neurons and the major classes of glial cells in culture.
    Raff MC; Fields KL; Hakomori SI; Mirsky R; Pruss RM; Winter J
    Brain Res; 1979 Oct; 174(2):283-308. PubMed ID: 385109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroimmunological findings in Guillain Barré syndrome, multiple sclerosis, and idiopathic polyneuropathies.
    Dorta-Contreras A; Silva-Somoza R
    Mol Chem Neuropathol; 1996; 28(1-3):279-84. PubMed ID: 8871970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunofluorescent staining of rat brain glial cells with multiple sclerosis serum.
    Singh VK; Mashal RD
    Can J Neurol Sci; 1981 May; 8(2):143-5. PubMed ID: 7028233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis serum and cerebrospinal fluid immunoglobulin binding to Fc receptors of oligodendrocytes.
    Ma BI; Joseph BS; Walsh MJ; Potvin AR; Tourtellotte WW
    Ann Neurol; 1981 Apr; 9(4):371-7. PubMed ID: 6452854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis: Serum anti-CNS autoantibodies.
    Prineas JW; Parratt JDE
    Mult Scler; 2018 Apr; 24(5):610-622. PubMed ID: 28548612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to oligodendroglia in patients with multiple sclerosis.
    Abramsky O; Lisak RP; Silberberg DH; Pleasure DE
    N Engl J Med; 1977 Dec; 297(22):1207-11. PubMed ID: 335246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cultured human and rat oligodendrocytes and rat Schwann cells do not have immune response gene associated antigen (Ia) on their surface.
    Lisak RP; Hirayama M; Kuchmy D; Rosenzweig A; Kim SU; Pleasure DE; Silberberg DH
    Brain Res; 1983 Dec; 289(1-2):285-92. PubMed ID: 6362776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Binding of immunoglobulins of the cerebrospinal fluid of multiple sclerosis patients to oligodendrocytes in culture].
    Lubetzki C; Lombrail P; Hauw JJ; Baumann N; Zalc B
    Pathol Biol (Paris); 1987 Mar; 35(3):314-8. PubMed ID: 3295697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligodendrocyte staining by multiple sclerosis serum is nonspecific.
    Traugott U; Snyder S; Raine CS
    Ann Neurol; 1979 Jul; 6(1):13-20. PubMed ID: 389147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical use of cerebrospinal fluid studies in demyelinating neurological diseases.
    Harrington MG; Kennedy PG
    Postgrad Med J; 1987 Sep; 63(743):735-40. PubMed ID: 3328189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis.
    Sanders ME; Koski CL; Robbins D; Shin ML; Frank MM; Joiner KA
    J Immunol; 1986 Jun; 136(12):4456-9. PubMed ID: 3711661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble complement receptor type 1 in serum and cerebrospinal fluid of patients with Guillain-Barré syndrome and multiple sclerosis.
    Vedeler CA; Matre R; Sadallah S; Schifferli J
    J Neuroimmunol; 1996 Jun; 67(1):17-20. PubMed ID: 8707926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of anti-neuronal antibodies in Alzheimer's disease.
    Watts H; Kennedy PG; Thomas M
    J Neuroimmunol; 1981 Mar; 1(1):107-16. PubMed ID: 7035490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to neurofilament, glial filament, and fibroblast intermediate filament proteins bind to different cell types of the nervous system.
    Yen SH; Fields KL
    J Cell Biol; 1981 Jan; 88(1):115-26. PubMed ID: 7193676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro demyelination by serum antibody from patients with Guillain-Barré syndrome requires terminal complement complexes.
    Sawant-Mane S; Clark MB; Koski CL
    Ann Neurol; 1991 Apr; 29(4):397-404. PubMed ID: 1718212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EAE, EAN and galactocerebroside sera bind to oligodendrocytes and Schwann cells.
    Lisak RP; Saida T; Kennedy PG; Saida K; Silberberg DH; Leibowitz S
    J Neurol Sci; 1980 Nov; 48(2):287-96. PubMed ID: 7000981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid pheresis in Guillain Barré syndrome.
    Wollinsky KH; Hülser PJ; Westarp ME; Mehrkens HH; Kornhuber HH
    Med Hypotheses; 1992 Jun; 38(2):155-65. PubMed ID: 1528158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.